555 related articles for article (PubMed ID: 19012362)
41. Insulin resistance is related with oxidative stress in systemic lupus erythematosus.
Koca SS; Karaca I; Yavuzkir MF; Dağli N; Ozgen M; Ustündağ B; Işik A
Anadolu Kardiyol Derg; 2009 Feb; 9(1):23-8. PubMed ID: 19196569
[TBL] [Abstract][Full Text] [Related]
42. Patients with systemic autoimmune diseases could not distinguish comorbidities from their index disease.
Hudson M; Bernatsky S; Taillefer S; Fortin PR; Wither J; Baron M; ;
J Clin Epidemiol; 2008 Jul; 61(7):654-62. PubMed ID: 18342489
[TBL] [Abstract][Full Text] [Related]
43. Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort.
Shinjo SK; Bonfá E; Wojdyla D; Borba EF; Ramirez LA; Scherbarth HR; Brenol JC; Chacón-Diaz R; Neira OJ; Berbotto GA; De La Torre IG; Acevedo-Vázquez EM; Massardo L; Barile-Fabris LA; Caeiro F; Silveira LH; Sato EI; Buliubasich S; Alarcón GS; Pons-Estel BA;
Arthritis Rheum; 2010 Mar; 62(3):855-62. PubMed ID: 20131238
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
45. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.
Cervera R; Khamashta MA; Font J; Sebastiani GD; Gil A; Lavilla P; Mejía JC; Aydintug AO; Chwalinska-Sadowska H; de Ramón E; Fernández-Nebro A; Galeazzi M; Valen M; Mathieu A; Houssiau F; Caro N; Alba P; Ramos-Casals M; Ingelmo M; Hughes GR;
Medicine (Baltimore); 2003 Sep; 82(5):299-308. PubMed ID: 14530779
[TBL] [Abstract][Full Text] [Related]
46. Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency.
Bensing S; Brandt L; Tabaroj F; Sjöberg O; Nilsson B; Ekbom A; Blomqvist P; Kämpe O
Clin Endocrinol (Oxf); 2008 Nov; 69(5):697-704. PubMed ID: 18727712
[TBL] [Abstract][Full Text] [Related]
47. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.
Sallai KK; Nagy E; Bodó I; Mohl A; Gergely P
Scand J Rheumatol; 2007; 36(3):198-205. PubMed ID: 17657674
[TBL] [Abstract][Full Text] [Related]
48. Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort.
Burling F; Ng J; Thein H; Ly J; Marshall MR; Gow P
Lupus; 2007; 16(10):830-7. PubMed ID: 17895308
[TBL] [Abstract][Full Text] [Related]
49. Risk of sudden sensorineural hearing loss in patients with systemic lupus erythematosus: a population-based cohort study.
Lin C; Lin SW; Weng SF; Lin YS
Audiol Neurootol; 2013; 18(2):95-100. PubMed ID: 23257626
[TBL] [Abstract][Full Text] [Related]
50. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies.
Descloux E; Durieu I; Cochat P; Vital Durand D; Ninet J; Fabien N; Cimaz R
Rheumatology (Oxford); 2008 Feb; 47(2):183-7. PubMed ID: 18160418
[TBL] [Abstract][Full Text] [Related]
51. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
Becker-Merok A; Nossent HC
J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
[TBL] [Abstract][Full Text] [Related]
52. Diet and systemic lupus erythematosus: a 4 year prospective study of Japanese patients.
Minami Y; Sasaki T; Arai Y; Kurisu Y; Hisamichi S
J Rheumatol; 2003 Apr; 30(4):747-54. PubMed ID: 12672194
[TBL] [Abstract][Full Text] [Related]
53. [Risk factors associated with systemic lupus erythematosis in a Mexican population].
Zonana-Nacach A; Rodríguez-Guzmán LM; Jiménez-Balderas FJ; Camargo-Coronel A; Escobedo-de la Peña J; Fraga A
Salud Publica Mex; 2002; 44(3):213-8. PubMed ID: 12132318
[TBL] [Abstract][Full Text] [Related]
54. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
[TBL] [Abstract][Full Text] [Related]
55. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
Appenzeller S; Pereira DA; Costallat LT
Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
[TBL] [Abstract][Full Text] [Related]
56. Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital.
Foocharoen C; Nanagara R; Salang L; Suwannaroj S; Mahakkanukrauh A
J Med Assoc Thai; 2009 Feb; 92(2):167-74. PubMed ID: 19253790
[TBL] [Abstract][Full Text] [Related]
57. Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain.
Sabio JM; Zamora-Pasadas M; Jiménez-Jáimez J; Albadalejo F; Vargas-Hitos J; Rodríguez del Aguila MD; Hidalgo-Tenorio C; Gonzalez-Gay MA; Jimenez-Alonso J
Lupus; 2008 Sep; 17(9):849-59. PubMed ID: 18755869
[TBL] [Abstract][Full Text] [Related]
58. Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus.
Mok CC; Ho LY; To CH
Scand J Rheumatol; 2009; 38(5):362-8. PubMed ID: 19296403
[TBL] [Abstract][Full Text] [Related]
59. Antiphospholipid syndrome and recurrent thrombosis in children.
Berkun Y; Padeh S; Barash J; Uziel Y; Harel L; Mukamel M; Revel-Vilk S; Kenet G
Arthritis Rheum; 2006 Dec; 55(6):850-5. PubMed ID: 17139660
[TBL] [Abstract][Full Text] [Related]
60. [Osteonecroses in systemic lupus erythematosus and antiphospholipid syndrome].
Reshetniak TM; Lisitsyna TA; Nasonov EL
Klin Med (Mosk); 2004; 82(6):46-51. PubMed ID: 15344691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
